Skip to content

Clinical trials

Phase 3 Joint Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Joint Diseases Phase: Phase 3 Country / region: Canada Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20085
20091
20101
20152
20162
20173
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie7
UCB Pharma2
Amgen1
Bayer1
Bioiberica1
Centre de recherche du Centre hospitalier universitaire de Sherbrooke1
Eli Lilly and Company1
Pfizer1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Joint Diseases16
Arthritis11
Arthritis, Rheumatoid9
Musculoskeletal Diseases9
Rheumatic Diseases3
Arthritis, Psoriatic2
Autoimmune Diseases2
Communicable Diseases2
Osteoarthritis2
Psoriasis2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.